Antitumor Immune Response Induced by DNA Vaccine Encoding Human Prostate-specific Membrane Antigen and Mouse 4-1BBL

These results suggest that a specific antitumor immune response is enhanced by DNA vaccines expressing PSMA and 4-1BBL. This approach could offer a new strategy for treating carcinoma of the prostate after standard therapy.